@article{47381ae62001408980fd58f11da04ee9,
title = "International study group of pediatric pancreatitis: In search for a Cu RE cohort study: Design and rationale for INSPPIRE 2 from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer",
abstract = "We created the INternational Study Group of Pediatric Pancreatitis: In Search for a CuRE (INSPPIRE 2) cohort to study the risk factors, natural history, and outcomes of pediatric acute recurrent pancreatitis and chronic pancreatitis (CP). Patient and physician questionnaires collect information on demographics, clinical history, family and social history, and disease outcomes. Health-related quality of life, depression, and anxiety are measured using validated questionnaires. Information entered on paper questionnaires is transferred into a database managed by Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer's Coordinating and Data Management Center. Biosamples are collected for DNA isolation and analysis of most common pancreatitis-associated genes. Twenty-two sites (18 in the United States, 2 in Canada, and 1 each in Israel and Australia) are participating in the INSPPIRE 2 study. These sites have enrolled 211 subjects into the INSPPIRE 2 database toward our goal to recruit more than 800 patients in 2 years. The INSPPIRE 2 cohort study is an extension of the INSPPIRE cohort study with a larger and more diverse patient population. Our goals have expanded to include evaluating risk factors for CP, its sequelae, and psychosocial factors associated with pediatric acute recurrent pancreatitis and CP.",
keywords = "Children, pancreatitis, registry",
author = "Aliye Uc and Perito, {Emily R.} and Pohl, {John F.} and Uzma Shah and Maisam Abu-El-Haija and Bradley Barth and Bellin, {Melena D.} and Ellery, {Kate M.} and Fishman, {Douglas S.} and Gariepy, {Cheryl E.} and Giefer, {Matthew J.} and Tanja Gonska and Heyman, {Melvin B.} and Himes, {Ryan W.} and Husain, {Sohail Z.} and Asim Maqbool and Mascarenhas, {Maria R.} and McFerron, {Brian A.} and Morinville, {Veronique D.} and Lin, {Tom K.} and Liu, {Quin Y.} and Nathan, {Jaimie D.} and Rhee, {Sue J.} and Ooi, {Chee Y.} and Sellers, {Zachary M.} and Schwarzenberg, {Sarah Jane} and Jose Serrano and Troendle, {David M.} and Werlin, {Steven L.} and Michael Wilschanski and Yuhua Zheng and Ying Yuan and Lowe, {Mark E.}",
note = "Funding Information: Research reported in this publication was supported by National Cancer Institute and the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award numbers R21DK096327, R01DK097820, U01DK108334, U01DK108300, U01DK108327, U01DK108326, U01DK108323, U01DK108328, U01DK108314, and U01DK108300. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Funding Information: Dr Mark Lowe is on the Board of Directors of the National Pancreas Foundation and receives royalties from Millipore Inc and UpToDate. Drs Tanja Gonska and Michael Wilschanski received a research grant from Vertex Pharmaceuticals. Dr Sohail Husain owns equity in PrevCon. Dr John Pohl is on the speaker's bureau for Medical Education Resources, Inc. Dr Melena Bellin is a consultant for AbbVie Inc and ARIEL Precision Medicine. Dr Aliye Uc is a member of American Board of Pediatrics, Subboard of Pediatric Gastroenterology. The other authors declare no conflicts of interest.",
year = "2018",
month = nov,
day = "1",
doi = "10.1097/MPA.0000000000001172",
language = "English (US)",
volume = "47",
pages = "1222--1228",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "10",
}